We’re thrilled to announce that Yadira Medina-Guevara has earned her Ph.D. After successfully defending her dissertation, “Advancing Targeted Radiopharmaceutical Therapy for Triple Negative Breast Cancer,” Yadira closes out a remarkable chapter in the ART Lab.

Triple negative breast cancer remains one of the toughest cases in oncology, with few targeted options available to patients. Yadira’s research worked to change that, developing radiopharmaceutical therapy approaches for a disease that has long resisted them.

Congratulations, Dr. Medina-Guevara. We can’t wait to see where you go from here!